Xencor | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
AbbVie USD 1.46B 1.86B 2025-03
Alnylam Pharmaceuticals USD 250.59M 135.16M 2025-06
Amgen USD 6.21B 330M 2025-03
Arrowhead Research USD 522.31M 161.91M 2025-06
AstraZeneca USD 44.72B 3.68B 2025-06
Biogen USD 17.63B 655.3M 2025-06
Bristol-Myers Squibb USD 17.49B 100M 2025-06
Cytokinetics USD -737440000 471.03M 2025-06
GlaxoSmithKline GBP 14.35B 197M 2025-06
J&J USD 78.11B 6.62B 2025-03
MacroGenics USD 116.06M 4.01M 2024-12
Merck USD 49.06B 725M 2025-06
Novartis USD 42.05B 3.6B 2025-06
Pfizer USD 88.7B 1.64B 2025-06
Regeneron Pharmaceuticals USD 29.94B 551.3M 2025-06
Roche Holding CHF 36.16B 3.28B 2024-12
Xencor USD 639.87M 37.74M 2025-03


Xencor Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.